We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$5.38B
AUM Growth
+$596M
Cap. Flow
+$425M
Cap. Flow %
7.9%
Top 10 Hldgs %
8.33%
Holding
1,582
New
122
Increased
396
Reduced
290
Closed
155

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$22.1M
2
PCG icon
PG&E
PCG
+$22.1M
3
MHK icon
Mohawk Industries
MHK
+$18M
4
HII icon
Huntington Ingalls Industries
HII
+$16.5M
5
DOX icon
Amdocs
DOX
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 21.25%
2 Industrials 14.51%
3 Technology 11.39%
4 Healthcare 11.36%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBN icon
1151
Northeast Bank
NBN
$1.13B
$368K 0.01%
35,000
OFG icon
1152
OFG Bancorp
OFG
$2.24B
$366K 0.01%
50,000
-92,600
-65% -$795K
SAIC icon
1153
Saic
SAIC
$5.08B
$366K 0.01%
8,000
DXYN
1154
DELISTED
Dixie Group Inc
DXYN
$366K 0.01%
70,000
FBNK
1155
DELISTED
First Connecticut Bancorp, Inc
FBNK
$366K 0.01%
21,050
-24,220
-54% -$418K
ISSC icon
1156
Innovative Solutions & Support
ISSC
$348M
$365K 0.01%
132,354
AAIC
1157
DELISTED
Arlington Asset Investment Corp.
AAIC
$363K 0.01%
27,400
BBQ
1158
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$361K 0.01%
52,000
STLY
1159
DELISTED
Stanley Furniture Co Inc
STLY
$361K 0.01%
129,383
ASYS icon
1160
Amtech Systems
ASYS
$275M
$360K 0.01%
57,500
PLX icon
1161
Protalix BioTherapeutics
PLX
$187M
$357K 0.01%
34,955
PXLW icon
1162
Pixelworks
PXLW
$39.3M
$357K 0.01%
12,492
SZYM
1163
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$357K 0.01%
143,896
+800
+0.6% +$2.37K
AX icon
1164
Axos Financial
AX
$5.9B
$354K 0.01%
16,800
-600
-3% -$14.1K
XOXO
1165
DELISTED
Xo Group Inc
XOXO
$353K 0.01%
22,000
-32,813
-60% -$523K
ESTE
1166
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$351K 0.01%
26,402
SUNE
1167
SUNation Energy
SUNE
$9.65M
0
STRR
1168
Star Equity Holdings
STRR
$39.6M
$349K 0.01%
11,941
KEQU icon
1169
Kewaunee Scientific
KEQU
$107M
$347K 0.01%
19,500
SCMP
1170
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$346K 0.01%
20,000
-500
-2% -$8.96K
LNTH icon
1171
Lantheus
LNTH
$6.59B
$345K 0.01%
+102,100
New +$367K
TCON
1172
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$343K 0.01%
186
+39
+27% +$78K
RHE
1173
DELISTED
Regional Health Properties, Inc.
RHE
$342K 0.01%
11,458
+9,375
+450% +$325K
LSBG
1174
DELISTED
Lake Sunapee Bank Group
LSBG
$340K 0.01%
24,250
ABAX
1175
DELISTED
Abaxis Inc
ABAX
$340K 0.01%
+6,100
New +$309K

Similar funds

Bridgeway Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Bridgeway Capital Management held 1,582 positions worth $5.38B, up 12% from $4.78B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Bridgeway Capital Management deployed $425M of net new capital in Q4 2015, opening 122 new positions and adding to 396 existing holdings. Its largest new stake was Lam Research: 3,995,450 shares worth $31.7M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Mohawk Industries, an estimated $18M trimmed.

  • Bridgeway Capital Management's largest Q4 2015 buy was Lam Research: 3,995,450 shares worth $31.7M.
  • Bridgeway Capital Management added most to Berkshire Hathaway Class B in Q4 2015, an estimated $29.5M increase.
  • Bridgeway Capital Management's biggest Q4 2015 reduction was Mohawk Industries, cutting an estimated $18M.
  • Bridgeway Capital Management fully exited Celanese in Q4 2015, selling an estimated $22.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.3% of its $5.38B portfolio in Q4 2015.
  • Bridgeway Capital Management opened 122 new positions and closed 155 in Q4 2015.
  • Bridgeway Capital Management's portfolio value rose 12% quarter-over-quarter to $5.38B.

Based on Bridgeway Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.